BG
IDYA icon

Bellevue Group’s IDEAYA Biosciences IDYA Stock Holding History

Bellevue Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,942
Closed -$171K – 175
2025
Q4 		$171K Buy
+4,942
New +$158K ﹤0.01% 156
2024
Q4 		– Sell
-7,200
Closed -$228K – 168
2024
Q3 		$228K Buy
7,200
+1,500
+26% +$56.9K ﹤0.01% 143
2024
Q2 		$200K Buy
5,700
+2,400
+73% +$95K ﹤0.01% 147
2024
Q1 		$145K Buy
+3,300
New +$142K ﹤0.01% 158
2022
Q2 		– Sell
-46,200
Closed -$517K – 177
2022
Q1 		$517K Sell
46,200
-800
-2% -$11.8K 0.01% 155
2021
Q4 		$1.11M Buy
+47,000
New +$1.09M 0.01% 153

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return